throbber
Trials@uspto.gov
`571-272-7822
`
`
`
`Paper 52
`Entered: February 15, 2024
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_______________
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_______________
`META PLATFORMS, INC.,
`Petitioner,
`v.
`THALES VISIONIX, INC.,
`Patent Owner.
`_______________
`
`IPR2022-01294 (Patent 8,224,024 B2)
`IPR2022-01304 (Patent 6,922,632 B2)
`IPR2022-01305 (Patent 6,922,632 B2)
`IPR2022-01308 (Patent 7,725,253 B2)
`_______________
`
`
`Before WILLIAM V. SAINDON, HYUN J. JUNG, and
`JASON W. MELVIN, Administrative Patent Judges.
`
`PER CURIAM.
`
`
`TERMINATION
`Due to Settlement After Institution of Trial
`35 U.S.C. § 317; 37 C.F.R. § 42.74
`
`
`
`
`
`
`
`
`

`

`IPR2022-01294 (Patent 8,224,024 B2)
`IPR2022-01304 (Patent 6,922,632 B2)
`IPR2022-01305 (Patent 6,922,632 B2)
`IPR2022-01308 (Patent 7,725,253 B2)
`
`Petitioner (Meta Platforms, Inc.) and Patent Owner (Thales Visionix,
`
`Inc.) have indicated that they have reached an agreement to settle each of the
`above-identified inter partes review proceedings. The Board authorized
`Petitioner and Patent Owner (collectively referred to as “the parties”) to file
`joint motions to terminate the proceedings on January 16, 2024.
`
`On January 17, 2024, pursuant to 37 C.F.R. § 42.74 and
`35 U.S.C. § 317(a), the parties filed joint motions to terminate each of the
`above-identified proceedings (Paper 441) and joint requests (Paper 432) to
`treat a confidential Patent License and Settlement Agreement as business
`confidential information and to keep the Patent License and Settlement
`Agreement separate from the files of the involved patents, along with a copy
`of the confidential Patent License and Settlement Agreement (Ex. 10423 (the
`“Meta-Gentex4 Agreement”)). Because the parties’ joint motions and joint
`requests did not appear to discharge the parties’ obligations under
`35 U.S.C. § 317(b), 5 the Board requested the parties, on January 26, 2024, to
`
`
`1 For purposes of expediency, we cite to Papers filed in IPR2022-01294.
`The parties submitted similar Joint Motions in IPR2022-01304 (Paper 49),
`IPR2022-01305 (Paper 50), and IPR2022-01308 (Paper 48).
`2 The parties submitted similar Joint Requests regarding the Patent License
`and Settlement Agreement in IPR2022-01304 (Paper 48), IPR2022-01305
`(Paper 49), and IPR2022-01308 (Paper 47).
`3 We cite to Exhibits filed in IPR2022-01294. The parties also submitted
`copies of confidential Patent License and Settlement Agreement in IPR2022-
`01304 (Ex. 1042), IPR2022-01305 (Exhibit 1042), and IPR2022-01308
`(Exhibit 1042).
`4 Gentex Corporation (“Gentex”) is Patent Owner’s licensee and real party-
`in-interest. See Paper 44, 1.
`5 In particular, the joint motions and joint requests (Papers 43 and 44) did
`
` 2
`
`
`
`
`
`

`

`IPR2022-01294 (Patent 8,224,024 B2)
`IPR2022-01304 (Patent 6,922,632 B2)
`IPR2022-01305 (Patent 6,922,632 B2)
`IPR2022-01308 (Patent 7,725,253 B2)
`
`re-file the motions and requests in order to make clear that the parties’
`submissions discharge their obligations under 35 U.S.C. § 317(b). See
`generally DTN, LLC v. Farms Technology, LLC, IPR2018-01412, Paper 21
`(PTAB June 14, 2019) (precedential) (explaining the requirements of
`35 U.S.C. § 317(b)).
`On February 5, 2024, the parties re-filed updated joint motions to
`terminate each of the above-identified proceedings (collectively “Joint
`Motions”) (Paper 466) and joint requests (collectively “Joint Requests”)
`(Paper 457) to treat the previously-filed Meta-Gentex Agreement (Ex. 1042)
`as business confidential information and to keep the Meta-Gentex
`Agreement separate from the files of the involved patents. The parties
`describe the filed copy of the confidential Meta-Gentex Agreement as
`comprising “a true copy of any ‘agreement or understanding … including
`any collateral agreements … made in connection with, or in contemplation
`of, the termination of’ th[ese] inter partes review[s].” Paper 46, 1–2; see
`also Paper 45, 1. The parties represent that the Meta-Gentex Agreement
`
`
`not certify that the filed Meta-Gentex Agreement is a “true copy” of the
`agreement, and also did not certify that there are no other collateral
`agreements or understandings made in connection with, or in contemplation
`of, the termination sought. See 35 U.S.C. § 317(b).
`6 The parties submitted similar Joint Motions in IPR2022-01304 (Paper 51),
`IPR2022-01305 (Paper 52), and IPR2022-01308 (Paper 50).
`7 The parties submitted similar Joint Requests regarding the Patent License
`and Settlement Agreement in IPR2022-01304 (Paper 50), IPR2022-01305
`(Paper 51), and IPR2022-01308 (Paper 49).
`
` 3
`
`
`
`
`
`

`

`IPR2022-01294 (Patent 8,224,024 B2)
`IPR2022-01304 (Patent 6,922,632 B2)
`IPR2022-01305 (Patent 6,922,632 B2)
`IPR2022-01308 (Patent 7,725,253 B2)
`
`resolves each of the above-identified proceedings as well as the related
`district court litigation.8 Paper 46, 2–4.
`Under 35 U.S.C. § 317(a), “[a]n inter partes review instituted under
`this chapter shall be terminated with respect to any petitioner upon the joint
`request of the petitioner and the patent owner, unless the Office has decided
`the merits of the proceeding before the request for termination is filed.”
`Section 35 U.S.C. § 317(a) also provides that if no petitioner remains in the
`inter partes review, the Office may terminate the review. The above-
`identified proceedings are at an intermediate stage. We have not yet decided
`the merits of these proceedings, and final written decisions have not been
`entered in these proceedings. Terminating these proceedings will save the
`Board administrative and judicial resources, e.g., in preparing and issuing a
`final written decision to decide the patentability issues raised in the
`respective Petitions. Furthermore, there are strong public policy reasons to
`favor settlement between the parties to a proceeding. Patent Trial and
`Appeal Board Consolidated Trial Practice Guide, 84 Fed. Reg. 64,280
`(Nov. 21, 2019). Under these circumstances, and in view of the parties’
`
`
`8 The parties identify the related district court litigation as Gentex
`Corporation et al. v. Meta Platforms, Inc. et al., No. 6:21-cv-00755-ADA
`(W.D. Tex.) (transferred to the Northern District of California as Case No.
`4:22-cv-03892-YGR). See Paper 46, 2–3. The parties note that Gentex and
`Indigo Technologies, LLC are “Voluntary Plaintiffs” in the district court
`litigation, with Patent Owner named as an involuntary plaintiff in the
`litigation, and submit that “the Voluntary Plaintiffs and Petitioner have filed
`a joint motion to dismiss the district court litigation.” Id.
`
` 4
`
`
`
`
`
`

`

`IPR2022-01294 (Patent 8,224,024 B2)
`IPR2022-01304 (Patent 6,922,632 B2)
`IPR2022-01305 (Patent 6,922,632 B2)
`IPR2022-01308 (Patent 7,725,253 B2)
`
`settlement and representations, we determine that good cause exists to
`terminate these proceedings. Accordingly, we grant the Joint Motions.
`The parties also “jointly request to file and treat the Patent License
`And Settlement Agreement between Petitioner and real party-in-interest
`Gentex Corporation (the ‘Meta-Gentex Agreement,’ Exhibit 1042) as
`business confidential information” and “jointly request that the confidential
`Meta-Gentex Agreement be kept separate from the file[s] of the subject
`patent[s] in the above-captioned proceeding[s] and be made available only to
`federal government agencies on written request or to persons showing good
`cause.” Paper 45, 1. We have reviewed the Meta-Gentex Agreement, which
`contains confidential business information regarding the terms of settlement,
`and we determine that good cause exists to treat the Meta-Gentex Agreement
`as business confidential information and to keep it separate from the files of
`the respective patents involved in the above-identified proceedings pursuant
`to 35 U.S.C. § 317(b) and 37 C.F.R. § 42.74(c). Accordingly, we grant the
`Joint Requests.
`This Order does not constitute a final written decision pursuant to
`35 U.S.C. § 318(a).
`Accordingly, it is:
`ORDERED that the Joint Motions (IPR2022-01294, Paper 46;
`IPR2022-01304, Paper 51; IPR2022-01305, Paper 52; and IPR2022-01308,
`Paper 50) to terminate the above-identified proceedings are granted, and that
`IPR2022-01294, IPR2022-01304, IPR2022-01305, and IPR2022-01308 are
`terminated;
`
` 5
`
`
`
`
`
`

`

`IPR2022-01294 (Patent 8,224,024 B2)
`IPR2022-01304 (Patent 6,922,632 B2)
`IPR2022-01305 (Patent 6,922,632 B2)
`IPR2022-01308 (Patent 7,725,253 B2)
`
`
`FURTHER ORDERED that the Joint Requests (IPR2022-01294,
`Paper 45; IPR2022-01304, Paper 50; IPR2022-01305, Paper 51; and
`IPR2022-01308, Paper 49) are granted, and the Meta-Gentex Agreement
`(IPR2022-01294, Ex. 1042; IPR2022-01304, Ex. 1042; IPR2022-01305,
`Ex. 1042; and IPR2022-01308, Ex. 1042) shall be treated as business
`confidential information, shall be kept separate from the files of the involved
`patents (U.S. Patent 8,224,024, U.S. Patent 6,922,632, and U.S. Patent
`7,725,253), and shall be made available only to Federal Government
`agencies on written request, or to any person on a showing of good cause on
`written request, pursuant to 35 U.S.C. § 317(b) and 37 C.F.R. § 42.74(c);
`and
`
`FURTHER ORDERED that Exhibit 1042 in IPR2022-01294,
`Exhibit 1042 in IPR2022-01304, Exhibit 1042 in IPR2022-01305, and
`Exhibit 1042 in IPR2022-01308 shall remain designated as “Board Only” in
`the Board’s P-TACTS system.
`
`
`
` 6
`
`
`
`
`
`
`
`
`
`

`

`IPR2022-01294 (Patent 8,224,024 B2)
`IPR2022-01304 (Patent 6,922,632 B2)
`IPR2022-01305 (Patent 6,922,632 B2)
`IPR2022-01308 (Patent 7,725,253 B2)
`
`FOR PETITIONER:
`
`W. Todd Baker
`Yimeng Dou
`Ellisen Shelton Turner
`Akshay S. Deoras
`KIRKLAND & ELLIS LLP
`todd.baker@kirkland.com
`yimeng.dou@kirkland.com
`ellisen.turner@kirkland.com
`akshay.deoras@kirkland.com
`
`
`FOR PATENT OWNER:
`
`Meredith Martin Addy
`Robert P. Hart
`Gregory B. Gulliver
`Brandon C. Helms
`ADDYHART P.C.
`meredith@addyhart.com
`robert@addyhart.com
`gbgulliver@addyhart.com
`bhelms@addyhart.com
`
`D. Shayon Ghosh
`Arthur J. Argall III
`Melissa B. Collins
`Adam D. Harber
`David M. Krinksy
`WILLIAMS & CONNOLLY LLP
`sghosh@wc.com
`aargall@wc.com
`mcollins@wc.com
`aharber@wc.com
`Gentex-IPR@wc.com
`
` 7
`
`
`
`
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket